Review
Published on 04 Mar 2022
Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.843345
- 6,610 views
- 18 citations
Type at least 3 characters
1,768 articles
Articles
Review
Published on 03 Mar 2022
Potential Role of APEX1 During Ferroptosis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.798304
- 6,814 views
- 10 citations
Original Research
Published on 02 Mar 2022
Targeting the lncRNA DUXAP8/miR-29a/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.773601
- 2,748 views
- 10 citations
Review
Published on 25 Feb 2022
Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.812534
- 8,131 views
- 17 citations
Original Research
Published on 24 Feb 2022
A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.837373
- 3,067 views
- 11 citations
Correction
Published on 24 Feb 2022
Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.860158
- 1,121 views
Original Research
Published on 24 Feb 2022
ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.840287
- 3,760 views
- 6 citations
Original Research
Published on 24 Feb 2022
All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.848517
- 2,807 views
- 7 citations
Original Research
Published on 24 Feb 2022
COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.707525
- 4,117 views
- 12 citations
Original Research
Published on 23 Feb 2022
Tumor-Derived Extracellular Vesicles Activate Normal Human Fibroblasts to a Cancer-Associated Fibroblast-Like Phenotype, Sustaining a Pro-Tumorigenic Microenvironment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.839880
- 5,363 views
- 30 citations
Original Research
Published on 23 Feb 2022
Transcriptional Expressions of ALDH1A1/B1 as Independent Indicators for the Survival of Thyroid Cancer Patients
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.821958
- 2,413 views
- 3 citations
Review
Published on 23 Feb 2022
Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.819563
- 12,524 views
- 59 citations
Original Research
Published on 22 Feb 2022
Circulating Tumor DNA Mutations in Progressive Gastrointestinal Stromal Tumors Identify Biomarkers of Treatment Resistance and Uncover Potential Therapeutic Strategies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.840843
- 3,854 views
- 10 citations
Brief Research Report
Published on 22 Feb 2022
ECM Depletion Is Required to Improve the Intratumoral Uptake of Iron Oxide Nanoparticles in Poorly Perfused Hepatocellular Carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.837234
- 2,392 views
- 3 citations
Original Research
Published on 21 Feb 2022
Single-Cell Transcriptome Comparison of Bladder Cancer Reveals Its Ecosystem
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.818147
- 9,789 views
- 12 citations
Original Research
Published on 21 Feb 2022
Actin Modulation Regulates the Alpha-1-Syntrophin/p66Shc Mediated Redox Signaling Contributing to the RhoA GTPase Protein Activation in Breast Cancer Cells
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.841303
- 2,284 views
- 2 citations